Patient and provider reported reasons for lost to follow up in MDRTB treatment: A qualitative study from a drug resistant TB Centre in India

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Deshmukh, Rajesh D ^a,c   Dhande, D J ^b   Sachdeva, Kuldeep Singh ^c   Sreenivas, Achuthan ^a   Kumar, A M V ^d   Satyanarayana, Srinath ^e   Parmar, Malik ^a   Moonan, Patrick K ^a   Lo, Terrence Q ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Lata Mangeshkar Hospital   (India)

^c GOVERNMENT OF INDIA   (India)

^d INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CONFUSION; CONTROLLED STUDY; DEPRESSION; DIRECTLY OBSERVED THERAPY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEADACHE; HEALTH PERSONNEL ATTITUDE; HUMAN; INDIA; MALE; MEDICATION COMPLIANCE; MENTAL DISEASE; MIDDLE AGED; MULTIDRUG RESISTANT TUBERCULOSIS; PATIENT ATTITUDE; PATIENT COMPLIANCE; QUALITATIVE RESEARCH; RESTLESSNESS; SEMI STRUCTURED INTERVIEW; SOCIAL BELIEF; SOCIAL DISCRIMINATION; SOCIAL STIGMA; SOCIAL SUPPORT; SUICIDAL IDEATION; TUBERCULOSIS CONTROL; VERTIGO; VOMITING; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; PATHOLOGY; PATHOPHYSIOLOGY; PUBLIC HEALTH; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ADULT; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; INDIA; LOST TO FOLLOW-UP; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PUBLIC HEALTH; QUALITATIVE RESEARCH; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84942937765     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135802     Document Type: Article

References (17)

1. Central Tuberculosis Division (2012) Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India, Directorate General of Health Services, Ministry of Health and Family Welfare. Government of India. Available: Http://www.tbcindia.nic.in. Accessed June 2015.
2. World Health Organization (2014) Global Tuberculosis Report 2013.WHO/HTM/TB/2014.08. Geneva, Switzerland: WHO.
3. Central Tuberculosis Division (2014) TB India 2014. Revised National TB Control Programme: Annual status report. Directorate General of Health Services, Ministry of Health and Family Welfare. Government of India. Available: Http://www.tbcindia.nic.in/. Accessed June 2015.
4. World Health Organization (2013) Definitions and Reporting Framework for Tuber- culosis 2013 revision. WHO/HTM/TB/2013.2 Geneva, Switzerland: WHO.
5. Gler M, Podewils L, Munez N, Galipot M, Quelapio M, Tupasi T (2012) Impact of patient and program factors on default during treatment of multidrug-resistant tub-erculosis. Int J Tuberc Lung Dis 2012 JJul 16 (7) : 955-960. doi: 10.5588/ijtld.11.0502 PMID: 22584124
6. Cox H, Beko B, Daniels J, Vazi A, Hughes J. Default from drug-resistant TB treatment in Khayelitsha: Risk factors and impact of long treatment duration (Poster) MSF. Available: Www.msf.lu/fileadmin/WEBLibrary/2-Au-Luxemburg/20.-Poster. Accessed June 2015.
7. Kurbatova EV, Taylor A, Gammino VM, Bayona J, Becerra M, Danilovitz M, et al. (2012) Predictors of poor outcomes among patients treated for multidrug-resistant tuber- culosis at DOTS-plus projects, Tuberculosis 92 (2012) ; 92: 397-403. doi: 10.1016/j.tube.2012.06.003 PMID: 22789497
8. Barnhoorn F, Adriaanse H (1992) In search of factors responsible for noncompliance among tuberculosis patients in Wardha District, India. Sm. Sci. Med 1992; 34: 291-306.
9. Shean K, Streicher E, Pieterson E, Symons G, van Zyl Smit R, Theron G, et al. (2013) Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa. PLoS One. 2013 May 7; 8 (5) .
10. Isaakidis P, Varghese B, Mansoor H, Cox HS, Ladomirska J, Saranchuk P, et al. (2012) Adverse events among HIV/MDR TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India. PLoS One. 2012; 7 (7) : E40781. doi: 10.1371/journal.pone.0040781 PMID: 22792406
11. Shin S, Pasechnikov A, Gelmanova I, Peremitin G, Strelis A, Mishustin S, et al. (2007) Adverse reactions among patients being treated for MDR TB in Tomsk, Russia.Int J Tuberc Lung Dis. 2007 Dec; 11 (12) : 1314-1320.
12. Vega P, Sweetland A, Acha J, Castillo H, Guerra D, Fawzi S, et al. (2004) Psychiatric issues in the management of patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2004 Jun; 8 (6) : 749-759 PMID: 15182146
13. Ahmad S, Mokaddas E (2009) Recent advances in the diagnosis and treatment of multidrug- resistant tuberculosis. 2009 Dec; 103 (12) : 1777-1790.
14. Gelmanova I, Keshavjee S, Golubchikova V, Berezina V, Strelis A, Yanova G, et al. (2007) Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: Non-adherence, default and the acquisition of multidrug resistance.Bulletin of the World Health Organization 2007; 85: 703-711. PMID: 18026627
15. Jakubowiak W, Bogorodskaya E, Borisov S, Danilova I, Lomakina O, Kourbatova E (2007) Social support and incentives programme for patients with tuberculosis: Experience from the Russian Federation Int J Tuberc Lung Dis 2007 Nov; 11 (11) : 1210-1215. PMID: 17958983
16. Shin S, Livchits V, Connery HS, Shields A, Yanov S, Yanova G, et al. (2013) Effectiveness of alcohol treatment interventions integrated into routine tuberculosis care in Tomsk, Russia. Addiction. 2013 Mar 14. [Epub ahead of print].
17. Jaiswal A, Singh V, Ogden J, Porter J, Sharma P, Sarin R, et al. (2003) Adherence to tuberculosis treatment: Lessons from the urban setting of Delhi, India Tropical Medicine and International Health .2003; 8: 625-633 PMID: 12828545